187 related articles for article (PubMed ID: 20651981)
41. Efficacy of PACE4 pharmacotherapy in JHU-LNCaP-SM preclinical model of androgen independent prostate cancer.
Mekdad N; Tran TMH; Desjardins R; Kwiatkowska A; Couture F; Day R
Sci Rep; 2022 Oct; 12(1):17489. PubMed ID: 36261691
[TBL] [Abstract][Full Text] [Related]
42. A novel cell-based sensor detecting the activity of individual basic proprotein convertases.
Löw K; Hardes K; Fedeli C; Seidah NG; Constam DB; Pasquato A; Steinmetzer T; Roulin A; Kunz S
FEBS J; 2019 Nov; 286(22):4597-4620. PubMed ID: 31276291
[TBL] [Abstract][Full Text] [Related]
43. Salivary gland development: its mediation by a subtilisin-like proprotein convertase, PACE4.
Akamatsu T; Azlina A; Javkhlan P; Hasegawa T; Yao C; Hosoi K
J Med Invest; 2009; 56 Suppl():241-6. PubMed ID: 20224189
[TBL] [Abstract][Full Text] [Related]
44. ADA-07 Suppresses Solar Ultraviolet-Induced Skin Carcinogenesis by Directly Inhibiting TOPK.
Gao G; Zhang T; Wang Q; Reddy K; Chen H; Yao K; Wang K; Roh E; Zykova T; Ma W; Ryu J; Curiel-Lewandrowski C; Alberts D; Dickinson SE; Bode AM; Xing Y; Dong Z
Mol Cancer Ther; 2017 Sep; 16(9):1843-1854. PubMed ID: 28655782
[TBL] [Abstract][Full Text] [Related]
45. Epigenetic regulation of proprotein convertase PACE4 gene expression in human ovarian cancer cells.
Fu Y; Campbell EJ; Shepherd TG; Nachtigal MW
Mol Cancer Res; 2003 Jun; 1(8):569-76. PubMed ID: 12805404
[TBL] [Abstract][Full Text] [Related]
46. Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy.
Khatib AM; Siegfried G; Chrétien M; Metrakos P; Seidah NG
Am J Pathol; 2002 Jun; 160(6):1921-35. PubMed ID: 12057895
[TBL] [Abstract][Full Text] [Related]
47. VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis.
Alitalo AK; Proulx ST; Karaman S; Aebischer D; Martino S; Jost M; Schneider N; Bry M; Detmar M
Cancer Res; 2013 Jul; 73(14):4212-21. PubMed ID: 23695550
[TBL] [Abstract][Full Text] [Related]
48. Proprotein convertase 5/6a is associated with bone morphogenetic protein-2-induced squamous cell differentiation.
Lee SN; Lee DH; Lee MG; Yoon JH
Am J Respir Cell Mol Biol; 2015 Jun; 52(6):749-61. PubMed ID: 25350918
[TBL] [Abstract][Full Text] [Related]
49. Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug.
Kwiatkowska A; Couture F; Ait-Mohand S; Desjardins R; Dory YL; Guérin B; Day R
Sci Rep; 2019 Feb; 9(1):2118. PubMed ID: 30765725
[TBL] [Abstract][Full Text] [Related]
50. Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7.
Scamuffa N; Basak A; Lalou C; Wargnier A; Marcinkiewicz J; Siegfried G; Chrétien M; Calvo F; Seidah NG; Khatib AM
Gut; 2008 Nov; 57(11):1573-82. PubMed ID: 18664504
[TBL] [Abstract][Full Text] [Related]
51. Decanoyl-Arg-Val-Lys-Arg-Chloromethylketone: An Antiviral Compound That Acts against Flaviviruses through the Inhibition of Furin-Mediated prM Cleavage.
Imran M; Saleemi MK; Chen Z; Wang X; Zhou D; Li Y; Zhao Z; Zheng B; Li Q; Cao S; Ye J
Viruses; 2019 Oct; 11(11):. PubMed ID: 31683742
[TBL] [Abstract][Full Text] [Related]
52. Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis.
Macias E; Kim Y; Miliani de Marval PL; Klein-Szanto A; Rodriguez-Puebla ML
Cancer Res; 2007 Oct; 67(20):9713-20. PubMed ID: 17942901
[TBL] [Abstract][Full Text] [Related]
53. Inhibitors of proprotein convertases.
Basak A
J Mol Med (Berl); 2005 Nov; 83(11):844-55. PubMed ID: 16215768
[TBL] [Abstract][Full Text] [Related]
54. Knockdown strategies for the study of proprotein convertases and proliferation in prostate cancer cells.
D'Anjou F; Couture F; Desjardins R; Day R
Methods Mol Biol; 2014; 1103():67-82. PubMed ID: 24318887
[TBL] [Abstract][Full Text] [Related]
55. Thrombin activation of protein C requires prior processing by a liver proprotein convertase.
Essalmani R; Susan-Resiga D; Guillemot J; Kim W; Sachan V; Awan Z; Chamberland A; Asselin MC; Ly K; Desjardins R; Day R; Prat A; Seidah NG
J Biol Chem; 2017 Jun; 292(25):10564-10573. PubMed ID: 28468828
[TBL] [Abstract][Full Text] [Related]
56. Imaging proprotein convertase activities and their regulation in the implanting mouse blastocyst.
Mesnard D; Constam DB
J Cell Biol; 2010 Oct; 191(1):129-39. PubMed ID: 20876279
[TBL] [Abstract][Full Text] [Related]
57. PACE4 Undergoes an Oncogenic Alternative Splicing Switch in Cancer.
Couture F; Sabbagh R; Kwiatkowska A; Desjardins R; Guay SP; Bouchard L; Day R
Cancer Res; 2017 Dec; 77(24):6863-6879. PubMed ID: 28993410
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of proprotein convertase SKI-1 blocks transcription of key extracellular matrix genes regulating osteoblastic mineralization.
Gorski JP; Huffman NT; Chittur S; Midura RJ; Black C; Oxford J; Seidah NG
J Biol Chem; 2011 Jan; 286(3):1836-49. PubMed ID: 21075843
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of furin/proprotein convertase-catalyzed surface and intracellular processing by small molecules.
Komiyama T; Coppola JM; Larsen MJ; van Dort ME; Ross BD; Day R; Rehemtulla A; Fuller RS
J Biol Chem; 2009 Jun; 284(23):15729-38. PubMed ID: 19332539
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions.
Khatib AM; Siegfried G; Prat A; Luis J; Chrétien M; Metrakos P; Seidah NG
J Biol Chem; 2001 Aug; 276(33):30686-93. PubMed ID: 11402025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
